Annovis Bio Inc (ANVS)

[tredenwater2]

Nice interview with your CEO. She speaks very candidly almost unguarded which is refreshing. It gives me a teeny bit more insight to the road Dr. Missling traveled at Anavex with respect to trial size, design, and timing. I also gained even more respect for his leadership as, while he hasnt conquered AD approval yet, we did just announced we are filing for approval with the EMA which tells me they have enough confidence in their SINGLE ph 2b/3 data ( using possibly the 1 year OLE as a supplemental) to gain approval.

I have to admit though it gives me pause when I see how low Anvs share price is and how far the company has to go. By time results from PD (which is the soonest I believe?) comes out, based on the current down trend of this thinly traded stock, the stock could be well sitting at $2-$3/share in preparation by the acquiring entity to gain leverage. Very low share count to date which has HF’s licking their chops at a secondary priced in the same range allowing them to sell into a news cycle…….a couple of times.

Regardless I hope the drug shines great light on much needed symptomatic relief for multiple Neurodegenerative diseases.

Cheers

Tred